Preterm Birth Prevention and Management Market Share

Statistics for the 2023 & 2024 Preterm Birth Prevention and Management market share, created by Mordor Intelligence™ Industry Reports. Preterm Birth Prevention and Management share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Preterm Birth Prevention and Management Industry

The global preterm birth prevention and management market is moderately competitive and consists of a few major players. Companies like AbbVie Inc., ObsEva, Covis Pharma GmbH (AMAG Pharmaceuticals, Inc.), Bayer AG, Ferring B.V., Merck & Co., Inc., Viatris Inc., Pfizer Inc., and Takeda Pharmaceutical Company Limited, among others, hold a substantial market share in the market.

Preterm Birth Prevention and Management Market Leaders

  1. Covis Pharma GmbH. (AMAG Pharmaceuticals, Inc.)

  2. Ferring B.V.

  3. Pfizer Inc.

  4. Takeda Pharmaceutical Company Limited.

  5. ObsEva

*Disclaimer: Major Players sorted in no particular order

Preterm Birth Prevention and Management Market Concentration

Preterm Birth Prevention & Management Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)